Investing

Also: Oma Fertility emerges from stealth with $37.5 million in equity and debt financing, and payer data platform Abacus Insights scores $28 million.

The startup's smartphone-administered digital therapeutic for fibromyalgia received FDA Breakthrough Device designation last year.

It will use the funds to deepen its presence across Asia.

The company plans to bring its technology to 10,000 more doctors in the country.

The round comes nearly a year after the company announced a $66 million Series C.

Also: Digital pathology startup Proscia raises $37 million in Series C funding.

The startup said the round brings its total raise to more than $50 million.

During a panel discussion at Going Digital: Behavioral Health Tech 2022, investors discuss what's next for the space as funding slows down, and explore the value of direct-to-consumer tools.

Also: Healthcare professional networking and data platform H1 adds another $23 million to its Series C round, and chronic condition management company DarioHealth secures a loan facility of up to $50 million.

The pandemic has forced major investment in digital health to help expand and create solutions that support patients and healthcare professionals through one of the most challenging times in history says Prof Sam Shah, Founder Faculty of Future Health, CoMD with Ulster University, visiting faculty UCL Global Business School for Health and HIMSS22 Europe speaker.